Son Truong Nguyen
Papers
4
Total Citations
8
H-Index
2
About
Son Truong Nguyen is a pioneering researcher in oral biologic drug delivery, with a focus on developing robotic pill platforms that transform the administration of large-molecule therapeutics. His major contributions center on demonstrating that an orally ingested robotic pill can safely and reliably deliver complex biologics—such as the human parathyroid hormone analog teriparatide, an ustekinumab biosimilar, and a follicle-stimulating hormone biosimilar—with high bioavailability in healthy human volunteers. In Phase 1 studies (2023–2024), Nguyen and his team showed that this platform achieves pharmacokinetic and pharmacodynamic profiles comparable to subcutaneous injection, offering a needle-free alternative for chronic conditions like osteoporosis and autoimmune diseases. Each of his most-cited papers has garnered 2 citations, reflecting early but significant interest from the scientific community. Notably, his work on patient preference for a once-daily FSH biosimilar via robotic pill addresses a critical unmet need in reproductive health. Nguyen’s research, conducted at Rani Therapeutics, represents a paradigm shift in drug delivery, potentially improving adherence and quality of life for millions of patients requiring frequent injections.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4